Future of the Global Artificial Intelligence (AI) In Drug Discovery Market: Trends, Innovations, and Key Forecasts Through 2034

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Artificial Intelligence (AI) In Drug Discovery Market Size Growth Forecast: What to Expect by 2025?
The valuation for the artificial intelligence sector within drug discovery has experienced remarkable, swift expansion lately; projecting forward, this market is anticipated to expand from a figure of $1.78 billion in the year 2024 to reach $2.33 billion by 2025, demonstrating a robust compound annual growth rate (CAGR) of 30.5%. This upward trajectory observed during the historical timeframe is primarily fueled by several factors, including the expansion witnessed in developing economies, the increasing incidence rates of long-term illnesses, the greater incorporation of AI technologies intended to make the process of finding new drugs more economical, and the progressively stringent quality mandates imposed upon pharmaceutical producers.

How Will the Artificial Intelligence (AI) In Drug Discovery Market Size Evolve and Grow by 2029?
Anticipating a surge, the market encompassing artificial intelligence utilization within pharmaceutical discovery processes is projected to expand dramatically over the coming years, reaching a valuation of $5.89 billion by 2029, driven by a compound annual growth rate (CAGR) equating to 26.1%. This upward trajectory throughout the projection timeframe stems from several factors, notably augmented backing from governmental bodies, escalating financial outlays in healare, and the progressively wider acceptance of services and applications hosted in the cloud. Key developments characterizing this period involve the incorporation of data from multiple omics fields, the application of AI techniques for identifying therapeutic targets, the deployment of artificial intelligence tools for assessing potential drug candidates, the establishment of dedicated AI innovation centers, and a rise in financial commitments channeled towards joint ventures and cooperative agreements.

View the full report here:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

What Drivers Are Propelling the Growth of Artificial Intelligence (AI) In Drug Discovery Market Forward?
Anticipation of increased consumer need for individually tailored medical treatments is likely to boost the expansion of artificial intelligence within the pharmaceutical exploration sector moving ahead. Personalized medicine involves creating medical interventions that guard against, identify, or remedy ailments based on an individual's genetic or protein makeup. AI possesses the potential for significant impact throughout every pertinent stage of clinical trials and the rollout of novel personalized health solutions by pinpointing suitable interaction targets and assessing those targets for their effectiveness. To illustrate this trend, data from the Personalized Medicine Coalition, a professional group situated in the US, showed that in 2022, the US Food and Drug Administration (FDA) authorized twelve personalized medications, representing roughly 34% of all new therapeutic molecular entities that received approval that year, as reported in February 2024, thereby illustrating how the rising interest in personalized healare fuels the adoption of AI in drug discovery activities.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3411&type=smp

Which Emerging Trends Are Transforming the Artificial Intelligence (AI) In Drug Discovery Market in 2025?
Key players in the realm of AI drug delivery are increasingly engaging in strategic alliances focused on leveraging artificial intelligence for drug research and subsequent discovery, which is consequently boosting their prominence within the artificial intelligence drug discovery sector. As an illustration, a notable agreement was established in August 2022 between Atomwise, an American firm specializing in AI systems, and the French pharmaceutical and healare entity, Sanofi. This collaboration was specifically designed to employ Atomwise's AtomNet technology, which is powered by artificial intelligence, for the computational identification and in-depth examination of as many as five distinct pharmacological targets. In exchange for using its capabilities to locate, develop, and progress lead compounds for these five targets, which remain exclusively Sanofi's, Atomwise was compensated an initial sum of $20 million by Sanofi.

What Are the Key Segments in the Artificial Intelligence (AI) In Drug Discovery Market?
The artificial intelligence (AI) in drug discoverymarket covered in this report is segmented -

1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning
2) By Drug Type: Small Molecules, Large Molecules
3) By Therapeutic Type: Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, Anti-Infective Diseases, Respiratory Diseases, Other Therapeutics
4) By End User: Pharmaceutical Companies, Biopharmaceutical Companies, Academic And Research Institutes, Other End-Users

Subsegments:
1) By Context-Aware Processing: Contextual Data Integration; Predictive Modeling; Adaptive Learning Systems
2) By Natural Language Processing (NLP): Text Mining And Analysis; Sentiment Analysis; Drug Interaction Extraction; Clinical Trial Data Analysis
3) By Querying Method: Semantic Search; Knowledge Graphs; Structured Query Language (SQL) Based Queries
4) By Deep Learning: Neural Networks; Convolutional Neural Networks (CNNs); Recurrent Neural Networks (RNNs); Reinforcement Learning Applications

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3411&type=smp

Who Are the Key Players Shaping the Artificial Intelligence (AI) In Drug Discovery Market's Competitive Landscape?
Major companies operating in the artificial intelligence (AI) in drug discovery market include IBM Corporation, Microsoft Corporation, NVIDIA Corporation, Exscientia, Alphabet, Insilico Medicine, Owkin Inc, Xtalpi Inc, Cloud Pharmaceuticals, Shanghai PharmaceuticS, Standigm, Indegene, Intuition Systems, Innoplexus, Takeda Pharmaceutical Company Ltd., RxPrism, Otsuka Pharmaceutical Co. Ltd., China National Pharmaceutical Group Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd, Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Sun Pharma, Tricog Health Services Pvt. Ltd., Alliance Pharm Pte Ltd., CytoReason, IIPharma, StoneWise, Adagene, GT Apeiron Therapeutics, Xbiome, Accutar Biotech, DeepMind, Renalytix AI, Iktos, Ipsen Pharma, Galderma S.A., BenevolentAI, Deepflare, Novartis, Gero, Ardigen, Botkin, Care Mentor AI, Diagnocat, GNS Healare, Merck & Co., Apotex, Pfizer, Gilead Sciences, Roche, Bayer, AbbVie Inc., GlaxoSmithKline, AstraZeneca, Amgen, Sanofi Pasteur, Abbott Laboratories, Teva Canada, Accord Healare Inc, Acerus Pharmaceuticals Corporation, AA Pharma Inc, Sanfer, Siegfried Rhein, Atomwise, Inc., Bioage, NuMedii, Envisagenics, Aria Pharmaceuticals, Verge Genomics, Berg LLC, Deep Genomics, Cyclica, IQVIA, Quris, GE Healare, Avanade, Group42 Holding Ltd, Ilara Health, Adcock Ingram, Johnson & Johnson, Eurolab, Ranbaxy (SA) (Pty) Ltd, Aspen, Rology, hearX Group, DilenyTech

What Geographic Markets Are Powering Growth in the Artificial Intelligence (AI) In Drug Discovery Market?
North America was the largest region in the artificial intelligence (AI) in drug discovery market in 2024. Western Europe was the second largest region in the global artificial intelligence (AI) in drug discovery market share. The regions covered in the artificial intelligence (AI) in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3411

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.